Cape Investment Advisory’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.8K Buy
+528
New +$34.7K 0.01% 596
2026
Q1
Sell
-339
Closed -$27.8K 578
2025
Q4
$27.8K Buy
339
+313
+1,204% +$24.4K 0.01% 547
2025
Q3
$1.95K Sell
26
-321
-93% -$23.9K ﹤0.01% 679
2025
Q2
$25.7K Sell
347
-11
-3% -$766 0.01% 469
2025
Q1
$28.9K Hold
358
0.01% 418
2024
Q4
$28K Buy
358
+33
+10% +$2.81K 0.01% 424
2024
Q3
$30.5K Hold
325
0.01% 391
2024
Q2
$25.3K Hold
325
0.01% 395
2024
Q1
$29.5K Sell
325
-115
-26% -$9.57K 0.01% 387
2023
Q4
$34K Sell
440
-14
-3% -$980 0.02% 426
2023
Q3
$30.9K Hold
454
0.02% 377
2023
Q2
$36.9K Hold
454
0.02% 336
2023
Q1
$37.2K Buy
+454
New +$32.4K 0.02% 322

Other funds holding GEHC

Cape Investment Advisory's GEHC Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in GE HealthCare (GEHC) in Q2 2026: 528 shares worth $33.8K. The stake represents 0.01% of the portfolio and ranks #596 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in GEHC as recently as Q4 2025.

Cape Investment Advisory first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $37.2K in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cape Investment Advisory held 528 shares of GE HealthCare worth $33.8K as of Q2 2026.
  • GE HealthCare was a new Cape Investment Advisory position in Q2 2026.
  • GE HealthCare made up 0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #596 holding.
  • Cape Investment Advisory first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Cape Investment Advisory's GE HealthCare position peaked at $37.2K in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.